
The following have been reloaded with a version change:
  1) GCCcore/8.3.0 => GCCcore/9.3.0
  2) binutils/2.32-GCCcore-8.3.0 => binutils/2.34-GCCcore-9.3.0
  3) zlib/1.2.11-GCCcore-8.3.0 => zlib/1.2.11-GCCcore-9.3.0

2021-01-19 05:43:50 | INFO | fairseq_cli.train | Namespace(activation_dropout=0.0, activation_fn='relu', adam_betas='(0.9, 0.98)', adam_eps=1e-08, adaptive_input=False, adaptive_softmax_cutoff=None, adaptive_softmax_dropout=0, all_gather_list_size=16384, arch='transformer_vaswani_wmt_en_de_big', attention_dropout=0.0, best_checkpoint_metric='loss', bf16=False, bpe=None, broadcast_buffers=False, bucket_cap_mb=25, checkpoint_suffix='', clip_norm=0.0, cpu=False, criterion='label_smoothed_cross_entropy', cross_self_attention=False, curriculum=0, data='../../../data-bin/custom_EMEA/orig_EMEA', data_buffer_size=10, dataset_impl=None, ddp_backend='c10d', decoder_attention_heads=16, decoder_embed_dim=1024, decoder_embed_path=None, decoder_ffn_embed_dim=4096, decoder_input_dim=1024, decoder_layerdrop=0, decoder_layers=6, decoder_layers_to_keep=None, decoder_learned_pos=False, decoder_normalize_before=False, decoder_output_dim=1024, device_id=0, disable_validation=False, distributed_backend='nccl', distributed_init_method=None, distributed_no_spawn=False, distributed_port=-1, distributed_rank=0, distributed_world_size=1, distributed_wrapper='DDP', dropout=0.5, empty_cache_freq=0, encoder_attention_heads=16, encoder_embed_dim=1024, encoder_embed_path=None, encoder_ffn_embed_dim=8192, encoder_layerdrop=0, encoder_layers=6, encoder_layers_to_keep=None, encoder_learned_pos=False, encoder_normalize_before=False, eval_bleu=True, eval_bleu_args='{"beam": 5, "max_len_a": 1.2, "max_len_b": 10}', eval_bleu_detok='moses', eval_bleu_detok_args=None, eval_bleu_print_samples=True, eval_bleu_remove_bpe='@@ ', eval_tokenized_bleu=False, fast_stat_sync=False, find_unused_parameters=False, fix_batches_to_gpus=False, fixed_validation_seed=None, fp16=True, fp16_init_scale=128, fp16_no_flatten_grads=False, fp16_scale_tolerance=0.0, fp16_scale_window=None, keep_best_checkpoints=-1, keep_interval_updates=-1, keep_last_epochs=-1, label_smoothing=0.1, layernorm_embedding=False, left_pad_source='True', left_pad_target='False', load_alignments=False, localsgd_frequency=3, log_format=None, log_interval=100, lr=[8e-06], lr_scheduler='inverse_sqrt', max_epoch=50, max_sentences=None, max_sentences_valid=None, max_source_positions=1024, max_target_positions=1024, max_tokens=4096, max_tokens_valid=4096, max_update=0, maximize_best_checkpoint_metric=False, memory_efficient_bf16=False, memory_efficient_fp16=False, min_loss_scale=0.0001, min_lr=-1, model_parallel_size=1, no_cross_attention=False, no_epoch_checkpoints=True, no_last_checkpoints=False, no_progress_bar=False, no_save=False, no_save_optimizer_state=False, no_scale_embedding=False, no_seed_provided=True, no_token_positional_embeddings=False, nprocs_per_node=1, num_batch_buckets=0, num_workers=1, optimizer='adam', optimizer_overrides='{}', patience=-1, profile=False, quant_noise_pq=0, quant_noise_pq_block_size=8, quant_noise_scalar=0, quantization_config_path=None, required_batch_size_multiple=8, reset_dataloader=True, reset_lr_scheduler=False, reset_meters=False, reset_optimizer=True, restore_file='../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt', save_dir='../checkpoints/EMEA_17', save_interval=1, save_interval_updates=0, scoring='bleu', seed=1, sentence_avg=False, share_all_embeddings=False, share_decoder_input_output_embed=True, skip_invalid_size_inputs_valid_test=False, slowmo_algorithm='LocalSGD', slowmo_momentum=None, source_lang=None, stop_time_hours=0, target_lang=None, task='translation', tensorboard_logdir='', threshold_loss_scale=None, tie_adaptive_weights=False, tokenizer=None, tpu=False, train_subset='train', truncate_source=False, update_freq=[1], upsample_primary=1, use_bmuf=False, use_old_adam=False, user_dir=None, valid_subset='valid', validate_after_updates=0, validate_interval=1, validate_interval_updates=0, warmup_init_lr=-1, warmup_updates=4000, weight_decay=1e-07)
2021-01-19 05:43:50 | INFO | fairseq.tasks.translation | [de] dictionary: 42024 types
2021-01-19 05:43:50 | INFO | fairseq.tasks.translation | [en] dictionary: 42024 types
2021-01-19 05:43:50 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/valid.de-en.de
2021-01-19 05:43:50 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/valid.de-en.en
2021-01-19 05:43:50 | INFO | fairseq.tasks.translation | ../../../data-bin/custom_EMEA/orig_EMEA valid de-en 151 examples
2021-01-19 05:43:54 | INFO | fairseq_cli.train | TransformerModel(
  (encoder): TransformerEncoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
  )
  (decoder): TransformerDecoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
    (output_projection): Linear(in_features=1024, out_features=42024, bias=False)
  )
)
2021-01-19 05:43:54 | INFO | fairseq_cli.train | model transformer_vaswani_wmt_en_de_big, criterion LabelSmoothedCrossEntropyCriterion
2021-01-19 05:43:54 | INFO | fairseq_cli.train | num. model params: 312778752 (num. trained: 312778752)
2021-01-19 05:43:57 | INFO | fairseq.trainer | detected shared parameter: decoder.embed_tokens.weight <- decoder.output_projection.weight
2021-01-19 05:43:57 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-01-19 05:43:57 | INFO | fairseq.utils | rank   0: capabilities =  7.0  ; total memory = 32.000 GB ; name = GRID V100D-32Q                          
2021-01-19 05:43:57 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-01-19 05:43:57 | INFO | fairseq_cli.train | training on 1 devices (GPUs/TPUs)
2021-01-19 05:43:57 | INFO | fairseq_cli.train | max tokens per GPU = 4096 and max sentences per GPU = None
2021-01-19 05:43:59 | INFO | fairseq.trainer | loaded checkpoint ../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt (epoch 16 @ 0 updates)
2021-01-19 05:43:59 | INFO | fairseq.trainer | loading train data for epoch 1
2021-01-19 05:43:59 | INFO | fairseq.data.data_utils | loaded 10001 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/train.de-en.de
2021-01-19 05:44:00 | INFO | fairseq.data.data_utils | loaded 10001 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/train.de-en.en
2021-01-19 05:44:00 | INFO | fairseq.tasks.translation | ../../../data-bin/custom_EMEA/orig_EMEA train de-en 10001 examples
2021-01-19 05:44:00 | INFO | fairseq_cli.train | begin training epoch 1
2021-01-19 05:44:00 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 64.0
2021-01-19 05:44:00 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 32.0
2021-01-19 05:44:00 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 16.0
2021-01-19 05:44:00 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 8.0
2021-01-19 05:44:02 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 4.0
2021-01-19 05:44:07 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 2.0
2021-01-19 05:44:18 | INFO | train_inner | epoch 001:    106 / 139 loss=5.441, nll_loss=4.019, ppl=16.22, wps=14101.2, ups=5.68, wpb=2476.1, bsz=73.5, num_updates=100, lr=2e-07, gnorm=15.684, loss_scale=3, train_wall=17, wall=21
2021-01-19 05:44:23 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:44:24 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:44:24 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:44:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:44:25 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:44:26 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms that are known as acute painful neuropathy and are usually reversible.
2021-01-19 05:44:26 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:44:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated hemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit did actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:44:29 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:44:29 | INFO | valid | epoch 001 | valid on 'valid' subset | loss 3.965 | nll_loss 2.247 | ppl 4.75 | bleu 31.39 | wps 745.2 | wpb 1083 | bsz 37.8 | num_updates 133
2021-01-19 05:44:29 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:45:03 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 1 @ 133 updates, score 3.965) (writing took 33.83197239693254 seconds)
2021-01-19 05:45:03 | INFO | fairseq_cli.train | end of epoch 1 (average epoch stats below)
2021-01-19 05:45:03 | INFO | train | epoch 001 | loss 5.4 | nll_loss 3.973 | ppl 15.7 | wps 5202.5 | ups 2.11 | wpb 2455.6 | bsz 72.4 | num_updates 133 | lr 2.66e-07 | gnorm 15.187 | loss_scale 4 | train_wall 24 | wall 66
2021-01-19 05:45:03 | INFO | fairseq_cli.train | begin training epoch 1
2021-01-19 05:45:15 | INFO | train_inner | epoch 002:     67 / 139 loss=5.261, nll_loss=3.815, ppl=14.08, wps=4371.8, ups=1.76, wpb=2480.6, bsz=74, num_updates=200, lr=4e-07, gnorm=13.514, loss_scale=2, train_wall=17, wall=78
2021-01-19 05:45:27 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:45:27 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:45:27 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:45:28 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:45:28 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:45:29 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms that are known as acute painful neuropathy and are usually reversible.
2021-01-19 05:45:29 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:45:32 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated hemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:45:32 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:45:32 | INFO | valid | epoch 002 | valid on 'valid' subset | loss 3.968 | nll_loss 2.237 | ppl 4.72 | bleu 32.13 | wps 773.8 | wpb 1083 | bsz 37.8 | num_updates 272 | best_loss 3.965
2021-01-19 05:45:32 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:45:50 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_last.pt (epoch 2 @ 272 updates, score 3.968) (writing took 17.420072950422764 seconds)
2021-01-19 05:45:50 | INFO | fairseq_cli.train | end of epoch 2 (average epoch stats below)
2021-01-19 05:45:50 | INFO | train | epoch 002 | loss 5.216 | nll_loss 3.762 | ppl 13.57 | wps 7329.1 | ups 2.98 | wpb 2458.3 | bsz 71.9 | num_updates 272 | lr 5.44e-07 | gnorm 12.829 | loss_scale 2 | train_wall 24 | wall 113
2021-01-19 05:45:50 | INFO | fairseq_cli.train | begin training epoch 2
2021-01-19 05:45:54 | INFO | train_inner | epoch 003:     28 / 139 loss=5.172, nll_loss=3.71, ppl=13.09, wps=5883.5, ups=2.52, wpb=2334, bsz=67.9, num_updates=300, lr=6e-07, gnorm=11.781, loss_scale=2, train_wall=17, wall=117
2021-01-19 05:46:12 | INFO | train_inner | epoch 003:    128 / 139 loss=4.941, nll_loss=3.444, ppl=10.88, wps=14581.6, ups=5.78, wpb=2522, bsz=75, num_updates=400, lr=8e-07, gnorm=11.809, loss_scale=2, train_wall=17, wall=135
2021-01-19 05:46:14 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:46:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:46:14 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:46:15 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:46:15 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:46:16 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms that are known as acute painful neuropathy and are usually reversible.
2021-01-19 05:46:16 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:46:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated hemoglobin (HbA1c), which indicates how well blood sugar is regulated. What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:46:19 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:46:19 | INFO | valid | epoch 003 | valid on 'valid' subset | loss 3.969 | nll_loss 2.22 | ppl 4.66 | bleu 31.97 | wps 753.4 | wpb 1083 | bsz 37.8 | num_updates 411 | best_loss 3.965
2021-01-19 05:46:19 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:46:31 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_last.pt (epoch 3 @ 411 updates, score 3.969) (writing took 12.064364954829216 seconds)
2021-01-19 05:46:31 | INFO | fairseq_cli.train | end of epoch 3 (average epoch stats below)
2021-01-19 05:46:31 | INFO | train | epoch 003 | loss 4.955 | nll_loss 3.46 | ppl 11 | wps 8239.8 | ups 3.35 | wpb 2458.3 | bsz 71.9 | num_updates 411 | lr 8.22e-07 | gnorm 11.314 | loss_scale 2 | train_wall 24 | wall 154
2021-01-19 05:46:31 | INFO | fairseq_cli.train | begin training epoch 3
2021-01-19 05:46:46 | INFO | train_inner | epoch 004:     89 / 139 loss=4.731, nll_loss=3.197, ppl=9.17, wps=7272, ups=2.87, wpb=2533, bsz=71.1, num_updates=500, lr=1e-06, gnorm=9.615, loss_scale=2, train_wall=17, wall=169
2021-01-19 05:46:55 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:46:55 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:46:55 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:46:56 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:46:56 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:46:57 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:46:57 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:47:00 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:47:00 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:47:01 | INFO | valid | epoch 004 | valid on 'valid' subset | loss 3.963 | nll_loss 2.189 | ppl 4.56 | bleu 30.87 | wps 731 | wpb 1083 | bsz 37.8 | num_updates 550 | best_loss 3.963
2021-01-19 05:47:01 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:47:38 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 4 @ 550 updates, score 3.963) (writing took 37.76712497230619 seconds)
2021-01-19 05:47:38 | INFO | fairseq_cli.train | end of epoch 4 (average epoch stats below)
2021-01-19 05:47:38 | INFO | train | epoch 004 | loss 4.79 | nll_loss 3.261 | ppl 9.59 | wps 5077.4 | ups 2.07 | wpb 2458.3 | bsz 71.9 | num_updates 550 | lr 1.1e-06 | gnorm 9.796 | loss_scale 2 | train_wall 24 | wall 221
2021-01-19 05:47:38 | INFO | fairseq_cli.train | begin training epoch 4
2021-01-19 05:47:47 | INFO | train_inner | epoch 005:     50 / 139 loss=4.77, nll_loss=3.23, ppl=9.38, wps=3972.5, ups=1.65, wpb=2410.9, bsz=72.3, num_updates=600, lr=1.2e-06, gnorm=9.379, loss_scale=2, train_wall=17, wall=230
2021-01-19 05:48:02 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:48:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:48:03 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:48:04 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:48:04 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:48:05 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:48:05 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:48:08 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid with a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood sugar is regulated. What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:48:08 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:48:08 | INFO | valid | epoch 005 | valid on 'valid' subset | loss 3.947 | nll_loss 2.145 | ppl 4.42 | bleu 31.43 | wps 721.6 | wpb 1083 | bsz 37.8 | num_updates 689 | best_loss 3.947
2021-01-19 05:48:08 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:48:45 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 5 @ 689 updates, score 3.947) (writing took 37.542582218535244 seconds)
2021-01-19 05:48:45 | INFO | fairseq_cli.train | end of epoch 5 (average epoch stats below)
2021-01-19 05:48:45 | INFO | train | epoch 005 | loss 4.634 | nll_loss 3.069 | ppl 8.39 | wps 5087.4 | ups 2.07 | wpb 2458.3 | bsz 71.9 | num_updates 689 | lr 1.378e-06 | gnorm 8.994 | loss_scale 2 | train_wall 24 | wall 289
2021-01-19 05:48:45 | INFO | fairseq_cli.train | begin training epoch 5
2021-01-19 05:48:47 | INFO | train_inner | epoch 006:     11 / 139 loss=4.631, nll_loss=3.062, ppl=8.35, wps=4057.7, ups=1.66, wpb=2443.4, bsz=70.6, num_updates=700, lr=1.4e-06, gnorm=9.637, loss_scale=2, train_wall=17, wall=290
2021-01-19 05:49:05 | INFO | train_inner | epoch 006:    111 / 139 loss=4.476, nll_loss=2.877, ppl=7.35, wps=14448.4, ups=5.77, wpb=2502.8, bsz=72.5, num_updates=800, lr=1.6e-06, gnorm=8.703, loss_scale=2, train_wall=17, wall=308
2021-01-19 05:49:09 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:49:10 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:49:10 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:49:11 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:49:11 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:49:12 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:49:12 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:49:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients). Actrapid has been compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood sugar is regulated. What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during 6 months of treatment with actrapid.
2021-01-19 05:49:14 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:49:14 | INFO | valid | epoch 006 | valid on 'valid' subset | loss 3.921 | nll_loss 2.096 | ppl 4.27 | bleu 33.55 | wps 907.3 | wpb 1083 | bsz 37.8 | num_updates 828 | best_loss 3.921
2021-01-19 05:49:14 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:49:54 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 6 @ 828 updates, score 3.921) (writing took 40.005281190387905 seconds)
2021-01-19 05:49:54 | INFO | fairseq_cli.train | end of epoch 6 (average epoch stats below)
2021-01-19 05:49:54 | INFO | train | epoch 006 | loss 4.514 | nll_loss 2.919 | ppl 7.56 | wps 4988.7 | ups 2.03 | wpb 2458.3 | bsz 71.9 | num_updates 828 | lr 1.656e-06 | gnorm 9.194 | loss_scale 2 | train_wall 24 | wall 357
2021-01-19 05:49:54 | INFO | fairseq_cli.train | begin training epoch 6
2021-01-19 05:50:06 | INFO | train_inner | epoch 007:     72 / 139 loss=4.489, nll_loss=2.882, ppl=7.37, wps=3785.7, ups=1.63, wpb=2328.8, bsz=69.9, num_updates=900, lr=1.8e-06, gnorm=9.589, loss_scale=2, train_wall=17, wall=369
2021-01-19 05:50:18 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:50:18 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:50:18 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:50:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:50:19 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:50:20 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:50:20 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:50:23 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients). Actrapid has been compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood sugar is regulated. What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during 6 months of treatment with actrapid.
2021-01-19 05:50:23 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:50:23 | INFO | valid | epoch 007 | valid on 'valid' subset | loss 3.892 | nll_loss 2.047 | ppl 4.13 | bleu 33.8 | wps 883.7 | wpb 1083 | bsz 37.8 | num_updates 967 | best_loss 3.892
2021-01-19 05:50:23 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:51:00 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 7 @ 967 updates, score 3.892) (writing took 37.76637258939445 seconds)
2021-01-19 05:51:00 | INFO | fairseq_cli.train | end of epoch 7 (average epoch stats below)
2021-01-19 05:51:00 | INFO | train | epoch 007 | loss 4.406 | nll_loss 2.786 | ppl 6.9 | wps 5145.3 | ups 2.09 | wpb 2458.3 | bsz 71.9 | num_updates 967 | lr 1.934e-06 | gnorm 9.631 | loss_scale 2 | train_wall 24 | wall 423
2021-01-19 05:51:00 | INFO | fairseq_cli.train | begin training epoch 7
2021-01-19 05:51:06 | INFO | train_inner | epoch 008:     33 / 139 loss=4.29, nll_loss=2.652, ppl=6.29, wps=4297.5, ups=1.67, wpb=2574.1, bsz=77.5, num_updates=1000, lr=2e-06, gnorm=8.948, loss_scale=2, train_wall=17, wall=429
2021-01-19 05:51:23 | INFO | train_inner | epoch 008:    133 / 139 loss=4.334, nll_loss=2.695, ppl=6.47, wps=14152.1, ups=5.81, wpb=2437.2, bsz=69.4, num_updates=1100, lr=2.2e-06, gnorm=8.479, loss_scale=2, train_wall=17, wall=446
2021-01-19 05:51:24 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:51:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:51:25 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:51:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:51:26 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:51:26 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:51:26 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:51:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients). Actrapid has been compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood sugar is regulated. What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during 6 months of treatment with actrapid.
2021-01-19 05:51:29 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:51:29 | INFO | valid | epoch 008 | valid on 'valid' subset | loss 3.858 | nll_loss 1.999 | ppl 4 | bleu 34.67 | wps 834.3 | wpb 1083 | bsz 37.8 | num_updates 1106 | best_loss 3.858
2021-01-19 05:51:29 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:52:08 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 8 @ 1106 updates, score 3.858) (writing took 39.117603613995016 seconds)
2021-01-19 05:52:08 | INFO | fairseq_cli.train | end of epoch 8 (average epoch stats below)
2021-01-19 05:52:08 | INFO | train | epoch 008 | loss 4.303 | nll_loss 2.661 | ppl 6.32 | wps 5025.8 | ups 2.04 | wpb 2458.3 | bsz 71.9 | num_updates 1106 | lr 2.212e-06 | gnorm 8.585 | loss_scale 2 | train_wall 24 | wall 491
2021-01-19 05:52:08 | INFO | fairseq_cli.train | begin training epoch 8
2021-01-19 05:52:24 | INFO | train_inner | epoch 009:     94 / 139 loss=4.247, nll_loss=2.595, ppl=6.04, wps=3949.7, ups=1.64, wpb=2414.9, bsz=68.2, num_updates=1200, lr=2.4e-06, gnorm=8.707, loss_scale=2, train_wall=17, wall=508
2021-01-19 05:52:32 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:52:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:52:33 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:52:34 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:52:34 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:52:34 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:52:34 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:52:37 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared to a human insulin analogue (insulin aspart) by measuring the concentration of a substance in the blood known as glycosylated haemoglobin (HbA1c) that indicates how well blood sugar is regulated. What benefit has actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with actrapid.
2021-01-19 05:52:37 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:52:37 | INFO | valid | epoch 009 | valid on 'valid' subset | loss 3.825 | nll_loss 1.954 | ppl 3.87 | bleu 35.87 | wps 781.9 | wpb 1083 | bsz 37.8 | num_updates 1245 | best_loss 3.825
2021-01-19 05:52:37 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:53:14 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 9 @ 1245 updates, score 3.825) (writing took 36.583044230006635 seconds)
2021-01-19 05:53:14 | INFO | fairseq_cli.train | end of epoch 9 (average epoch stats below)
2021-01-19 05:53:14 | INFO | train | epoch 009 | loss 4.211 | nll_loss 2.553 | ppl 5.87 | wps 5198.4 | ups 2.11 | wpb 2458.3 | bsz 71.9 | num_updates 1245 | lr 2.49e-06 | gnorm 8.128 | loss_scale 2 | train_wall 24 | wall 557
2021-01-19 05:53:14 | INFO | fairseq_cli.train | begin training epoch 9
2021-01-19 05:53:24 | INFO | train_inner | epoch 010:     55 / 139 loss=4.137, nll_loss=2.467, ppl=5.53, wps=4189.4, ups=1.69, wpb=2479.5, bsz=73.8, num_updates=1300, lr=2.6e-06, gnorm=7.845, loss_scale=2, train_wall=17, wall=567
2021-01-19 05:53:38 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:53:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:53:39 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:53:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:53:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:53:40 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:53:40 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:53:44 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood sugar is regulated.
2021-01-19 05:53:44 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:53:44 | INFO | valid | epoch 010 | valid on 'valid' subset | loss 3.787 | nll_loss 1.907 | ppl 3.75 | bleu 35.83 | wps 721 | wpb 1083 | bsz 37.8 | num_updates 1384 | best_loss 3.787
2021-01-19 05:53:44 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:54:20 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 10 @ 1384 updates, score 3.787) (writing took 36.6315695932135 seconds)
2021-01-19 05:54:20 | INFO | fairseq_cli.train | end of epoch 10 (average epoch stats below)
2021-01-19 05:54:20 | INFO | train | epoch 010 | loss 4.126 | nll_loss 2.453 | ppl 5.48 | wps 5151.4 | ups 2.1 | wpb 2458.3 | bsz 71.9 | num_updates 1384 | lr 2.768e-06 | gnorm 8.076 | loss_scale 2 | train_wall 24 | wall 623
2021-01-19 05:54:20 | INFO | fairseq_cli.train | begin training epoch 10
2021-01-19 05:54:23 | INFO | train_inner | epoch 011:     16 / 139 loss=4.137, nll_loss=2.465, ppl=5.52, wps=4185.9, ups=1.68, wpb=2496.3, bsz=69.9, num_updates=1400, lr=2.8e-06, gnorm=8.173, loss_scale=2, train_wall=17, wall=626
2021-01-19 05:54:40 | INFO | train_inner | epoch 011:    116 / 139 loss=4.047, nll_loss=2.363, ppl=5.14, wps=14121.7, ups=5.87, wpb=2404.6, bsz=74.7, num_updates=1500, lr=3e-06, gnorm=8.528, loss_scale=2, train_wall=17, wall=643
2021-01-19 05:54:44 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:54:45 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:54:45 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:54:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:54:46 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:54:47 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:54:47 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:54:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood sugar is regulated.
2021-01-19 05:54:50 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:54:50 | INFO | valid | epoch 011 | valid on 'valid' subset | loss 3.754 | nll_loss 1.867 | ppl 3.65 | bleu 35.85 | wps 739 | wpb 1083 | bsz 37.8 | num_updates 1523 | best_loss 3.754
2021-01-19 05:54:50 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:55:25 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 11 @ 1523 updates, score 3.754) (writing took 34.860826722346246 seconds)
2021-01-19 05:55:25 | INFO | fairseq_cli.train | end of epoch 11 (average epoch stats below)
2021-01-19 05:55:25 | INFO | train | epoch 011 | loss 4.068 | nll_loss 2.387 | ppl 5.23 | wps 5305.8 | ups 2.16 | wpb 2458.3 | bsz 71.9 | num_updates 1523 | lr 3.046e-06 | gnorm 8.343 | loss_scale 2 | train_wall 24 | wall 688
2021-01-19 05:55:25 | INFO | fairseq_cli.train | begin training epoch 11
2021-01-19 05:55:38 | INFO | train_inner | epoch 012:     77 / 139 loss=4.013, nll_loss=2.323, ppl=5.01, wps=4401.2, ups=1.73, wpb=2549.4, bsz=72.8, num_updates=1600, lr=3.2e-06, gnorm=7.582, loss_scale=2, train_wall=17, wall=701
2021-01-19 05:55:49 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:55:49 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:55:49 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:55:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:55:50 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:55:51 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:55:51 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:55:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared to a human insulin analogue (insulin Aspart) by measuring the concentration of a substance in the blood known as glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is regulated.
2021-01-19 05:55:54 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:55:54 | INFO | valid | epoch 012 | valid on 'valid' subset | loss 3.717 | nll_loss 1.825 | ppl 3.54 | bleu 36.29 | wps 744.1 | wpb 1083 | bsz 37.8 | num_updates 1662 | best_loss 3.717
2021-01-19 05:55:54 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:56:30 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 12 @ 1662 updates, score 3.717) (writing took 35.73364951647818 seconds)
2021-01-19 05:56:30 | INFO | fairseq_cli.train | end of epoch 12 (average epoch stats below)
2021-01-19 05:56:30 | INFO | train | epoch 012 | loss 3.991 | nll_loss 2.298 | ppl 4.92 | wps 5236.3 | ups 2.13 | wpb 2458.3 | bsz 71.9 | num_updates 1662 | lr 3.324e-06 | gnorm 7.418 | loss_scale 2 | train_wall 24 | wall 753
2021-01-19 05:56:30 | INFO | fairseq_cli.train | begin training epoch 12
2021-01-19 05:56:37 | INFO | train_inner | epoch 013:     38 / 139 loss=3.977, nll_loss=2.283, ppl=4.87, wps=4097.2, ups=1.71, wpb=2391.1, bsz=72.8, num_updates=1700, lr=3.4e-06, gnorm=7.303, loss_scale=2, train_wall=17, wall=760
2021-01-19 05:56:55 | INFO | train_inner | epoch 013:    138 / 139 loss=3.92, nll_loss=2.216, ppl=4.65, wps=13555.4, ups=5.51, wpb=2461.4, bsz=69.9, num_updates=1800, lr=3.6e-06, gnorm=6.996, loss_scale=2, train_wall=18, wall=778
2021-01-19 05:56:55 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:56:55 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:56:55 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:56:56 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:56:56 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:56:57 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:56:57 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:57:00 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is regulated.
2021-01-19 05:57:00 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:57:00 | INFO | valid | epoch 013 | valid on 'valid' subset | loss 3.691 | nll_loss 1.791 | ppl 3.46 | bleu 37.02 | wps 744.1 | wpb 1083 | bsz 37.8 | num_updates 1801 | best_loss 3.691
2021-01-19 05:57:00 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:57:35 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 13 @ 1801 updates, score 3.691) (writing took 34.66978918109089 seconds)
2021-01-19 05:57:35 | INFO | fairseq_cli.train | end of epoch 13 (average epoch stats below)
2021-01-19 05:57:35 | INFO | train | epoch 013 | loss 3.92 | nll_loss 2.218 | ppl 4.65 | wps 5257.1 | ups 2.14 | wpb 2458.3 | bsz 71.9 | num_updates 1801 | lr 3.602e-06 | gnorm 7.143 | loss_scale 2 | train_wall 25 | wall 818
2021-01-19 05:57:35 | INFO | fairseq_cli.train | begin training epoch 13
2021-01-19 05:57:52 | INFO | train_inner | epoch 014:     99 / 139 loss=3.848, nll_loss=2.136, ppl=4.39, wps=4388.7, ups=1.74, wpb=2524, bsz=72.4, num_updates=1900, lr=3.8e-06, gnorm=7.214, loss_scale=2, train_wall=17, wall=835
2021-01-19 05:57:59 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:58:00 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:58:00 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:58:00 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used with long acting insulin preparations.
2021-01-19 05:58:00 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:58:01 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:58:01 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:58:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared with a human insulin analogue (insulin Aspart) by measuring the concentration of a substance in the blood known as glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is regulated.
2021-01-19 05:58:05 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:58:05 | INFO | valid | epoch 014 | valid on 'valid' subset | loss 3.649 | nll_loss 1.742 | ppl 3.34 | bleu 37.93 | wps 729.5 | wpb 1083 | bsz 37.8 | num_updates 1940 | best_loss 3.649
2021-01-19 05:58:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:58:42 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 14 @ 1940 updates, score 3.649) (writing took 36.91769416630268 seconds)
2021-01-19 05:58:42 | INFO | fairseq_cli.train | end of epoch 14 (average epoch stats below)
2021-01-19 05:58:42 | INFO | train | epoch 014 | loss 3.864 | nll_loss 2.154 | ppl 4.45 | wps 5139.5 | ups 2.09 | wpb 2458.3 | bsz 71.9 | num_updates 1940 | lr 3.88e-06 | gnorm 7.13 | loss_scale 2 | train_wall 24 | wall 885
2021-01-19 05:58:42 | INFO | fairseq_cli.train | begin training epoch 14
2021-01-19 05:58:52 | INFO | train_inner | epoch 015:     60 / 139 loss=3.82, nll_loss=2.103, ppl=4.3, wps=4074.6, ups=1.67, wpb=2434.5, bsz=73, num_updates=2000, lr=4e-06, gnorm=7.112, loss_scale=2, train_wall=17, wall=895
2021-01-19 05:59:06 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:59:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:59:06 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:59:07 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used with long acting insulin preparations.
2021-01-19 05:59:07 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:59:08 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:59:08 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:59:11 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is regulated.
2021-01-19 05:59:11 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:59:11 | INFO | valid | epoch 015 | valid on 'valid' subset | loss 3.613 | nll_loss 1.699 | ppl 3.25 | bleu 38.58 | wps 755.2 | wpb 1083 | bsz 37.8 | num_updates 2079 | best_loss 3.613
2021-01-19 05:59:11 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:59:46 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 15 @ 2079 updates, score 3.613) (writing took 35.498238866217434 seconds)
2021-01-19 05:59:46 | INFO | fairseq_cli.train | end of epoch 15 (average epoch stats below)
2021-01-19 05:59:46 | INFO | train | epoch 015 | loss 3.806 | nll_loss 2.086 | ppl 4.25 | wps 5261.5 | ups 2.14 | wpb 2458.3 | bsz 71.9 | num_updates 2079 | lr 4.158e-06 | gnorm 6.992 | loss_scale 2 | train_wall 24 | wall 950
2021-01-19 05:59:46 | INFO | fairseq_cli.train | begin training epoch 15
2021-01-19 05:59:50 | INFO | train_inner | epoch 016:     21 / 139 loss=3.855, nll_loss=2.141, ppl=4.41, wps=4192.7, ups=1.72, wpb=2441.7, bsz=68.4, num_updates=2100, lr=4.2e-06, gnorm=8.384, loss_scale=2, train_wall=17, wall=953
2021-01-19 06:00:07 | INFO | train_inner | epoch 016:    121 / 139 loss=3.706, nll_loss=1.973, ppl=3.93, wps=14337.3, ups=5.82, wpb=2465.6, bsz=72.9, num_updates=2200, lr=4.4e-06, gnorm=6.808, loss_scale=2, train_wall=17, wall=970
2021-01-19 06:00:11 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:00:11 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:00:11 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:00:12 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used with long acting insulin preparations.
2021-01-19 06:00:12 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:00:13 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:00:13 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:00:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is regulated.
2021-01-19 06:00:16 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:00:16 | INFO | valid | epoch 016 | valid on 'valid' subset | loss 3.573 | nll_loss 1.652 | ppl 3.14 | bleu 38.85 | wps 703.1 | wpb 1083 | bsz 37.8 | num_updates 2218 | best_loss 3.573
2021-01-19 06:00:16 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:00:55 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 16 @ 2218 updates, score 3.573) (writing took 38.271771900355816 seconds)
2021-01-19 06:00:55 | INFO | fairseq_cli.train | end of epoch 16 (average epoch stats below)
2021-01-19 06:00:55 | INFO | train | epoch 016 | loss 3.746 | nll_loss 2.017 | ppl 4.05 | wps 5019 | ups 2.04 | wpb 2458.3 | bsz 71.9 | num_updates 2218 | lr 4.436e-06 | gnorm 7.89 | loss_scale 2 | train_wall 24 | wall 1018
2021-01-19 06:00:55 | INFO | fairseq_cli.train | begin training epoch 16
2021-01-19 06:01:09 | INFO | train_inner | epoch 017:     82 / 139 loss=3.775, nll_loss=2.05, ppl=4.14, wps=3961.7, ups=1.63, wpb=2429.5, bsz=67.3, num_updates=2300, lr=4.6e-06, gnorm=7.468, loss_scale=2, train_wall=17, wall=1032
2021-01-19 06:01:19 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:01:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:01:19 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:01:20 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used with long acting insulin preparations.
2021-01-19 06:01:20 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:01:21 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:01:21 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:01:23 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) indicating how well blood glucose is regulated.
2021-01-19 06:01:23 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:01:23 | INFO | valid | epoch 017 | valid on 'valid' subset | loss 3.544 | nll_loss 1.617 | ppl 3.07 | bleu 40.54 | wps 1011.5 | wpb 1083 | bsz 37.8 | num_updates 2357 | best_loss 3.544
2021-01-19 06:01:23 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:02:00 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 17 @ 2357 updates, score 3.544) (writing took 37.319309897720814 seconds)
2021-01-19 06:02:00 | INFO | fairseq_cli.train | end of epoch 17 (average epoch stats below)
2021-01-19 06:02:00 | INFO | train | epoch 017 | loss 3.704 | nll_loss 1.97 | ppl 3.92 | wps 5212.5 | ups 2.12 | wpb 2458.3 | bsz 71.9 | num_updates 2357 | lr 4.714e-06 | gnorm 6.918 | loss_scale 2 | train_wall 24 | wall 1083
2021-01-19 06:02:00 | INFO | fairseq_cli.train | begin training epoch 17
2021-01-19 06:02:08 | INFO | train_inner | epoch 018:     43 / 139 loss=3.625, nll_loss=1.881, ppl=3.68, wps=4185.6, ups=1.7, wpb=2462.6, bsz=79.8, num_updates=2400, lr=4.8e-06, gnorm=6.975, loss_scale=2, train_wall=17, wall=1091
2021-01-19 06:02:24 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:02:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:02:25 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:02:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used with long acting insulin preparations.
2021-01-19 06:02:26 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:02:26 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:02:26 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:02:28 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients). Actrapid has been compared with a human insulin analogue (insulin Aspart) by measuring the concentration of a substance in the blood known as glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is regulated.
2021-01-19 06:02:28 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:02:28 | INFO | valid | epoch 018 | valid on 'valid' subset | loss 3.508 | nll_loss 1.578 | ppl 2.99 | bleu 40.73 | wps 1006 | wpb 1083 | bsz 37.8 | num_updates 2496 | best_loss 3.508
2021-01-19 06:02:28 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:03:04 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 18 @ 2496 updates, score 3.508) (writing took 35.09177396632731 seconds)
2021-01-19 06:03:04 | INFO | fairseq_cli.train | end of epoch 18 (average epoch stats below)
2021-01-19 06:03:04 | INFO | train | epoch 018 | loss 3.652 | nll_loss 1.91 | ppl 3.76 | wps 5389.9 | ups 2.19 | wpb 2458.3 | bsz 71.9 | num_updates 2496 | lr 4.992e-06 | gnorm 7.211 | loss_scale 2 | train_wall 24 | wall 1147
2021-01-19 06:03:04 | INFO | fairseq_cli.train | begin training epoch 18
2021-01-19 06:03:04 | INFO | train_inner | epoch 019:      4 / 139 loss=3.645, nll_loss=1.901, ppl=3.73, wps=4325.2, ups=1.77, wpb=2450.3, bsz=69, num_updates=2500, lr=5e-06, gnorm=6.568, loss_scale=2, train_wall=17, wall=1147
2021-01-19 06:03:10 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 1.0
2021-01-19 06:03:22 | INFO | train_inner | epoch 019:    105 / 139 loss=3.592, nll_loss=1.841, ppl=3.58, wps=14458.5, ups=5.68, wpb=2545.8, bsz=74.5, num_updates=2600, lr=5.2e-06, gnorm=6.278, loss_scale=1, train_wall=17, wall=1165
2021-01-19 06:03:27 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:03:28 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:03:28 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:03:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used with long acting insulin preparations.
2021-01-19 06:03:29 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:03:30 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:03:30 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:03:32 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration of a substance in the blood known as glycosylated haemoglobin (HbA1c) that indicates how well glucose is regulated.
2021-01-19 06:03:32 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:03:32 | INFO | valid | epoch 019 | valid on 'valid' subset | loss 3.475 | nll_loss 1.538 | ppl 2.9 | bleu 41.46 | wps 1026.2 | wpb 1083 | bsz 37.8 | num_updates 2634 | best_loss 3.475
2021-01-19 06:03:32 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:04:06 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 19 @ 2634 updates, score 3.475) (writing took 34.308279938064516 seconds)
2021-01-19 06:04:06 | INFO | fairseq_cli.train | end of epoch 19 (average epoch stats below)
2021-01-19 06:04:06 | INFO | train | epoch 019 | loss 3.583 | nll_loss 1.832 | ppl 3.56 | wps 5441.7 | ups 2.21 | wpb 2459.3 | bsz 72.4 | num_updates 2634 | lr 5.268e-06 | gnorm 6.405 | loss_scale 1 | train_wall 24 | wall 1209
2021-01-19 06:04:06 | INFO | fairseq_cli.train | begin training epoch 19
2021-01-19 06:04:17 | INFO | train_inner | epoch 020:     66 / 139 loss=3.537, nll_loss=1.779, ppl=3.43, wps=4253, ups=1.8, wpb=2358.6, bsz=73.6, num_updates=2700, lr=5.4e-06, gnorm=6.195, loss_scale=1, train_wall=17, wall=1220
2021-01-19 06:04:30 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:04:30 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:04:30 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:04:31 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used with long acting insulin preparations.
2021-01-19 06:04:31 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:04:32 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:04:32 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:04:34 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration of a substance in the blood known as glycosylated haemoglobin (HbA1c) that indicates how well glucose is regulated.
2021-01-19 06:04:34 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:04:34 | INFO | valid | epoch 020 | valid on 'valid' subset | loss 3.438 | nll_loss 1.494 | ppl 2.82 | bleu 42.11 | wps 1030.1 | wpb 1083 | bsz 37.8 | num_updates 2773 | best_loss 3.438
2021-01-19 06:04:34 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:05:08 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 20 @ 2773 updates, score 3.438) (writing took 34.06548470351845 seconds)
2021-01-19 06:05:08 | INFO | fairseq_cli.train | end of epoch 20 (average epoch stats below)
2021-01-19 06:05:08 | INFO | train | epoch 020 | loss 3.555 | nll_loss 1.799 | ppl 3.48 | wps 5503.2 | ups 2.24 | wpb 2458.3 | bsz 71.9 | num_updates 2773 | lr 5.546e-06 | gnorm 6.926 | loss_scale 1 | train_wall 24 | wall 1271
2021-01-19 06:05:08 | INFO | fairseq_cli.train | begin training epoch 20
2021-01-19 06:05:13 | INFO | train_inner | epoch 021:     27 / 139 loss=3.598, nll_loss=1.847, ppl=3.6, wps=4446.6, ups=1.8, wpb=2463.6, bsz=65.5, num_updates=2800, lr=5.6e-06, gnorm=7.841, loss_scale=1, train_wall=17, wall=1276
2021-01-19 06:05:30 | INFO | train_inner | epoch 021:    127 / 139 loss=3.431, nll_loss=1.659, ppl=3.16, wps=14543, ups=5.83, wpb=2496.2, bsz=76.8, num_updates=2900, lr=5.8e-06, gnorm=5.714, loss_scale=1, train_wall=17, wall=1293
2021-01-19 06:05:32 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:05:32 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:05:32 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:05:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used with long acting insulin preparations.
2021-01-19 06:05:33 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:05:34 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:05:34 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:05:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well the blood glucose is regulated.
2021-01-19 06:05:36 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:05:36 | INFO | valid | epoch 021 | valid on 'valid' subset | loss 3.408 | nll_loss 1.459 | ppl 2.75 | bleu 43.03 | wps 1027 | wpb 1083 | bsz 37.8 | num_updates 2912 | best_loss 3.408
2021-01-19 06:05:36 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:06:11 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 21 @ 2912 updates, score 3.408) (writing took 34.47548686340451 seconds)
2021-01-19 06:06:11 | INFO | fairseq_cli.train | end of epoch 21 (average epoch stats below)
2021-01-19 06:06:11 | INFO | train | epoch 021 | loss 3.496 | nll_loss 1.732 | ppl 3.32 | wps 5461.6 | ups 2.22 | wpb 2458.3 | bsz 71.9 | num_updates 2912 | lr 5.824e-06 | gnorm 6.134 | loss_scale 1 | train_wall 24 | wall 1334
2021-01-19 06:06:11 | INFO | fairseq_cli.train | begin training epoch 21
2021-01-19 06:06:26 | INFO | train_inner | epoch 022:     88 / 139 loss=3.46, nll_loss=1.689, ppl=3.23, wps=4404.1, ups=1.79, wpb=2465, bsz=69.8, num_updates=3000, lr=6e-06, gnorm=6.217, loss_scale=1, train_wall=17, wall=1349
2021-01-19 06:06:34 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:06:35 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:06:35 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:06:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used with long acting insulin preparations.
2021-01-19 06:06:36 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:06:37 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:06:37 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:06:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration of a substance in the blood known as glycosylated haemoglobin (HbA1c) that indicates how well glucose is regulated.
2021-01-19 06:06:39 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:06:39 | INFO | valid | epoch 022 | valid on 'valid' subset | loss 3.364 | nll_loss 1.413 | ppl 2.66 | bleu 44.25 | wps 1027.9 | wpb 1083 | bsz 37.8 | num_updates 3051 | best_loss 3.364
2021-01-19 06:06:39 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:07:13 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 22 @ 3051 updates, score 3.364) (writing took 34.09328378364444 seconds)
2021-01-19 06:07:13 | INFO | fairseq_cli.train | end of epoch 22 (average epoch stats below)
2021-01-19 06:07:13 | INFO | train | epoch 022 | loss 3.463 | nll_loss 1.694 | ppl 3.24 | wps 5496.1 | ups 2.24 | wpb 2458.3 | bsz 71.9 | num_updates 3051 | lr 6.102e-06 | gnorm 6.297 | loss_scale 1 | train_wall 24 | wall 1396
2021-01-19 06:07:13 | INFO | fairseq_cli.train | begin training epoch 22
2021-01-19 06:07:21 | INFO | train_inner | epoch 023:     49 / 139 loss=3.496, nll_loss=1.732, ppl=3.32, wps=4386.5, ups=1.8, wpb=2432.9, bsz=74, num_updates=3100, lr=6.2e-06, gnorm=6.499, loss_scale=1, train_wall=17, wall=1404
2021-01-19 06:07:37 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:07:37 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:07:37 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:07:38 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-19 06:07:38 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:07:39 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:07:39 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:07:41 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas cannot produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (one trial involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) indicating how well the blood glucose is regulated for six months.
2021-01-19 06:07:41 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:07:41 | INFO | valid | epoch 023 | valid on 'valid' subset | loss 3.337 | nll_loss 1.38 | ppl 2.6 | bleu 45.08 | wps 1035.5 | wpb 1083 | bsz 37.8 | num_updates 3190 | best_loss 3.337
2021-01-19 06:07:41 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:08:16 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 23 @ 3190 updates, score 3.337) (writing took 35.66956810280681 seconds)
2021-01-19 06:08:16 | INFO | fairseq_cli.train | end of epoch 23 (average epoch stats below)
2021-01-19 06:08:16 | INFO | train | epoch 023 | loss 3.41 | nll_loss 1.634 | ppl 3.1 | wps 5363.6 | ups 2.18 | wpb 2458.3 | bsz 71.9 | num_updates 3190 | lr 6.38e-06 | gnorm 5.956 | loss_scale 1 | train_wall 24 | wall 1459
2021-01-19 06:08:16 | INFO | fairseq_cli.train | begin training epoch 23
2021-01-19 06:08:18 | INFO | train_inner | epoch 024:     10 / 139 loss=3.375, nll_loss=1.594, ppl=3.02, wps=4332.9, ups=1.76, wpb=2468, bsz=70.3, num_updates=3200, lr=6.4e-06, gnorm=5.537, loss_scale=1, train_wall=17, wall=1461
2021-01-19 06:08:36 | INFO | train_inner | epoch 024:    110 / 139 loss=3.366, nll_loss=1.584, ppl=3, wps=14442.4, ups=5.77, wpb=2502.5, bsz=73.6, num_updates=3300, lr=6.6e-06, gnorm=5.902, loss_scale=1, train_wall=17, wall=1479
2021-01-19 06:08:40 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:08:41 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:08:41 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:08:42 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-19 06:08:42 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:08:43 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:08:43 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:08:45 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas cannot produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (one trial involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) indicating how well the blood glucose is regulated for six months.
2021-01-19 06:08:45 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:08:45 | INFO | valid | epoch 024 | valid on 'valid' subset | loss 3.305 | nll_loss 1.344 | ppl 2.54 | bleu 45.45 | wps 1039.6 | wpb 1083 | bsz 37.8 | num_updates 3329 | best_loss 3.305
2021-01-19 06:08:45 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:09:21 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 24 @ 3329 updates, score 3.305) (writing took 36.53070155438036 seconds)
2021-01-19 06:09:21 | INFO | fairseq_cli.train | end of epoch 24 (average epoch stats below)
2021-01-19 06:09:21 | INFO | train | epoch 024 | loss 3.374 | nll_loss 1.593 | ppl 3.02 | wps 5286.2 | ups 2.15 | wpb 2458.3 | bsz 71.9 | num_updates 3329 | lr 6.658e-06 | gnorm 5.979 | loss_scale 1 | train_wall 24 | wall 1524
2021-01-19 06:09:21 | INFO | fairseq_cli.train | begin training epoch 24
2021-01-19 06:09:33 | INFO | train_inner | epoch 025:     71 / 139 loss=3.397, nll_loss=1.618, ppl=3.07, wps=4111.4, ups=1.74, wpb=2367.4, bsz=71.7, num_updates=3400, lr=6.8e-06, gnorm=5.904, loss_scale=1, train_wall=17, wall=1536
2021-01-19 06:09:45 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:09:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:09:46 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:09:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-19 06:09:46 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:09:47 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:09:47 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:09:49 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas cannot produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) indicating how well the blood glucose is regulated for six months.
2021-01-19 06:09:49 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:09:49 | INFO | valid | epoch 025 | valid on 'valid' subset | loss 3.282 | nll_loss 1.317 | ppl 2.49 | bleu 45.85 | wps 1038.1 | wpb 1083 | bsz 37.8 | num_updates 3468 | best_loss 3.282
2021-01-19 06:09:49 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:10:23 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 25 @ 3468 updates, score 3.282) (writing took 33.87562926579267 seconds)
2021-01-19 06:10:23 | INFO | fairseq_cli.train | end of epoch 25 (average epoch stats below)
2021-01-19 06:10:23 | INFO | train | epoch 025 | loss 3.326 | nll_loss 1.537 | ppl 2.9 | wps 5515.7 | ups 2.24 | wpb 2458.3 | bsz 71.9 | num_updates 3468 | lr 6.936e-06 | gnorm 5.59 | loss_scale 1 | train_wall 24 | wall 1586
2021-01-19 06:10:23 | INFO | fairseq_cli.train | begin training epoch 25
2021-01-19 06:10:29 | INFO | train_inner | epoch 026:     32 / 139 loss=3.247, nll_loss=1.448, ppl=2.73, wps=4541.7, ups=1.81, wpb=2515.4, bsz=68.7, num_updates=3500, lr=7e-06, gnorm=5.604, loss_scale=1, train_wall=17, wall=1592
2021-01-19 06:10:46 | INFO | train_inner | epoch 026:    132 / 139 loss=3.305, nll_loss=1.514, ppl=2.86, wps=14267, ups=5.82, wpb=2452.5, bsz=73.1, num_updates=3600, lr=7.2e-06, gnorm=5.683, loss_scale=1, train_wall=17, wall=1609
2021-01-19 06:10:47 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:10:48 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:10:48 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:10:48 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-19 06:10:48 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:10:49 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:10:49 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:10:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration of a substance in the blood known as glycosylated haemoglobin (HbA1c) that indicates how well the blood glucose is regulated over six months.
2021-01-19 06:10:51 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:10:51 | INFO | valid | epoch 026 | valid on 'valid' subset | loss 3.256 | nll_loss 1.285 | ppl 2.44 | bleu 46.59 | wps 1047 | wpb 1083 | bsz 37.8 | num_updates 3607 | best_loss 3.256
2021-01-19 06:10:51 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:11:26 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 26 @ 3607 updates, score 3.256) (writing took 34.62219993211329 seconds)
2021-01-19 06:11:26 | INFO | fairseq_cli.train | end of epoch 26 (average epoch stats below)
2021-01-19 06:11:26 | INFO | train | epoch 026 | loss 3.285 | nll_loss 1.491 | ppl 2.81 | wps 5456.2 | ups 2.22 | wpb 2458.3 | bsz 71.9 | num_updates 3607 | lr 7.214e-06 | gnorm 5.657 | loss_scale 1 | train_wall 24 | wall 1649
2021-01-19 06:11:26 | INFO | fairseq_cli.train | begin training epoch 26
2021-01-19 06:11:42 | INFO | train_inner | epoch 027:     93 / 139 loss=3.251, nll_loss=1.453, ppl=2.74, wps=4501.9, ups=1.78, wpb=2528.5, bsz=73.6, num_updates=3700, lr=7.4e-06, gnorm=5.494, loss_scale=1, train_wall=17, wall=1665
2021-01-19 06:11:50 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:11:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:11:50 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:11:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-19 06:11:51 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:11:52 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:11:52 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:11:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated, for six months.
2021-01-19 06:11:54 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:11:54 | INFO | valid | epoch 027 | valid on 'valid' subset | loss 3.234 | nll_loss 1.257 | ppl 2.39 | bleu 47.54 | wps 1024.2 | wpb 1083 | bsz 37.8 | num_updates 3746 | best_loss 3.234
2021-01-19 06:11:54 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:12:29 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 27 @ 3746 updates, score 3.234) (writing took 34.88608452305198 seconds)
2021-01-19 06:12:29 | INFO | fairseq_cli.train | end of epoch 27 (average epoch stats below)
2021-01-19 06:12:29 | INFO | train | epoch 027 | loss 3.244 | nll_loss 1.445 | ppl 2.72 | wps 5418.5 | ups 2.2 | wpb 2458.3 | bsz 71.9 | num_updates 3746 | lr 7.492e-06 | gnorm 5.438 | loss_scale 1 | train_wall 24 | wall 1712
2021-01-19 06:12:29 | INFO | fairseq_cli.train | begin training epoch 27
2021-01-19 06:12:38 | INFO | train_inner | epoch 028:     54 / 139 loss=3.241, nll_loss=1.441, ppl=2.71, wps=4197.4, ups=1.78, wpb=2357.1, bsz=68.2, num_updates=3800, lr=7.6e-06, gnorm=5.671, loss_scale=1, train_wall=17, wall=1721
2021-01-19 06:12:53 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:12:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:12:53 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:12:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used in conjunction with long acting insulin preparations.
2021-01-19 06:12:54 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:12:55 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:12:55 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:12:57 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas cannot produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:12:57 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:12:57 | INFO | valid | epoch 028 | valid on 'valid' subset | loss 3.207 | nll_loss 1.224 | ppl 2.34 | bleu 49.3 | wps 1020.5 | wpb 1083 | bsz 37.8 | num_updates 3885 | best_loss 3.207
2021-01-19 06:12:57 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:13:32 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 28 @ 3885 updates, score 3.207) (writing took 35.48390753287822 seconds)
2021-01-19 06:13:32 | INFO | fairseq_cli.train | end of epoch 28 (average epoch stats below)
2021-01-19 06:13:32 | INFO | train | epoch 028 | loss 3.206 | nll_loss 1.401 | ppl 2.64 | wps 5366.5 | ups 2.18 | wpb 2458.3 | bsz 71.9 | num_updates 3885 | lr 7.77e-06 | gnorm 5.723 | loss_scale 1 | train_wall 24 | wall 1775
2021-01-19 06:13:32 | INFO | fairseq_cli.train | begin training epoch 28
2021-01-19 06:13:35 | INFO | train_inner | epoch 029:     15 / 139 loss=3.205, nll_loss=1.401, ppl=2.64, wps=4348.9, ups=1.76, wpb=2477.1, bsz=75.2, num_updates=3900, lr=7.8e-06, gnorm=5.549, loss_scale=1, train_wall=17, wall=1778
2021-01-19 06:13:52 | INFO | train_inner | epoch 029:    115 / 139 loss=3.134, nll_loss=1.322, ppl=2.5, wps=14119.6, ups=5.85, wpb=2414.7, bsz=68.8, num_updates=4000, lr=8e-06, gnorm=5.126, loss_scale=1, train_wall=17, wall=1795
2021-01-19 06:13:56 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:13:57 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:13:57 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:13:58 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:13:58 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:13:58 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:13:58 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:14:00 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapid to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:14:00 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:14:00 | INFO | valid | epoch 029 | valid on 'valid' subset | loss 3.181 | nll_loss 1.194 | ppl 2.29 | bleu 50.27 | wps 1052.2 | wpb 1083 | bsz 37.8 | num_updates 4024 | best_loss 3.181
2021-01-19 06:14:00 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:14:34 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 29 @ 4024 updates, score 3.181) (writing took 34.11389921698719 seconds)
2021-01-19 06:14:34 | INFO | fairseq_cli.train | end of epoch 29 (average epoch stats below)
2021-01-19 06:14:34 | INFO | train | epoch 029 | loss 3.168 | nll_loss 1.359 | ppl 2.56 | wps 5504.1 | ups 2.24 | wpb 2458.3 | bsz 71.9 | num_updates 4024 | lr 7.97611e-06 | gnorm 5.388 | loss_scale 1 | train_wall 24 | wall 1838
2021-01-19 06:14:34 | INFO | fairseq_cli.train | begin training epoch 29
2021-01-19 06:14:48 | INFO | train_inner | epoch 030:     76 / 139 loss=3.139, nll_loss=1.326, ppl=2.51, wps=4483.4, ups=1.81, wpb=2483, bsz=77, num_updates=4100, lr=7.90184e-06, gnorm=5.342, loss_scale=1, train_wall=17, wall=1851
2021-01-19 06:14:58 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:14:59 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:14:59 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:15:00 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used with long-acting insulin preparations.
2021-01-19 06:15:00 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:15:01 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:15:01 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:15:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes in which the pancreas cannot produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:15:03 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:15:03 | INFO | valid | epoch 030 | valid on 'valid' subset | loss 3.158 | nll_loss 1.167 | ppl 2.25 | bleu 51.2 | wps 1038.4 | wpb 1083 | bsz 37.8 | num_updates 4163 | best_loss 3.158
2021-01-19 06:15:03 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:15:38 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 30 @ 4163 updates, score 3.158) (writing took 35.67223467491567 seconds)
2021-01-19 06:15:38 | INFO | fairseq_cli.train | end of epoch 30 (average epoch stats below)
2021-01-19 06:15:38 | INFO | train | epoch 030 | loss 3.134 | nll_loss 1.32 | ppl 2.5 | wps 5358.6 | ups 2.18 | wpb 2458.3 | bsz 71.9 | num_updates 4163 | lr 7.84182e-06 | gnorm 5.124 | loss_scale 1 | train_wall 24 | wall 1901
2021-01-19 06:15:38 | INFO | fairseq_cli.train | begin training epoch 30
2021-01-19 06:15:45 | INFO | train_inner | epoch 031:     37 / 139 loss=3.136, nll_loss=1.323, ppl=2.5, wps=4325.8, ups=1.75, wpb=2470.9, bsz=72, num_updates=4200, lr=7.8072e-06, gnorm=5.139, loss_scale=1, train_wall=17, wall=1908
2021-01-19 06:16:02 | INFO | train_inner | epoch 031:    137 / 139 loss=3.098, nll_loss=1.279, ppl=2.43, wps=14287.1, ups=5.82, wpb=2455.2, bsz=70.2, num_updates=4300, lr=7.71589e-06, gnorm=5.149, loss_scale=1, train_wall=17, wall=1925
2021-01-19 06:16:02 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:16:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:16:03 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:16:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:16:03 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:16:04 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:16:04 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:16:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes in which the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes in which the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:16:06 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:16:06 | INFO | valid | epoch 031 | valid on 'valid' subset | loss 3.132 | nll_loss 1.135 | ppl 2.2 | bleu 52.29 | wps 1053.2 | wpb 1083 | bsz 37.8 | num_updates 4302 | best_loss 3.132
2021-01-19 06:16:06 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:16:40 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 31 @ 4302 updates, score 3.132) (writing took 34.10925508942455 seconds)
2021-01-19 06:16:40 | INFO | fairseq_cli.train | end of epoch 31 (average epoch stats below)
2021-01-19 06:16:40 | INFO | train | epoch 031 | loss 3.098 | nll_loss 1.279 | ppl 2.43 | wps 5500.5 | ups 2.24 | wpb 2458.3 | bsz 71.9 | num_updates 4302 | lr 7.71409e-06 | gnorm 5.104 | loss_scale 1 | train_wall 24 | wall 1963
2021-01-19 06:16:40 | INFO | fairseq_cli.train | begin training epoch 31
2021-01-19 06:16:57 | INFO | train_inner | epoch 032:     98 / 139 loss=3.074, nll_loss=1.251, ppl=2.38, wps=4461.8, ups=1.81, wpb=2469.4, bsz=70.3, num_updates=4400, lr=7.6277e-06, gnorm=5.322, loss_scale=1, train_wall=17, wall=1980
2021-01-19 06:17:04 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:17:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:17:05 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:17:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used with long-acting insulin preparations.
2021-01-19 06:17:06 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:17:06 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 06:17:06 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:17:08 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes in which the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes in which the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled, for six months.
2021-01-19 06:17:08 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:17:08 | INFO | valid | epoch 032 | valid on 'valid' subset | loss 3.117 | nll_loss 1.12 | ppl 2.17 | bleu 52.62 | wps 1039.1 | wpb 1083 | bsz 37.8 | num_updates 4441 | best_loss 3.117
2021-01-19 06:17:08 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:17:43 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 32 @ 4441 updates, score 3.117) (writing took 34.50634993053973 seconds)
2021-01-19 06:17:43 | INFO | fairseq_cli.train | end of epoch 32 (average epoch stats below)
2021-01-19 06:17:43 | INFO | train | epoch 032 | loss 3.063 | nll_loss 1.239 | ppl 2.36 | wps 5464.2 | ups 2.22 | wpb 2458.3 | bsz 71.9 | num_updates 4441 | lr 7.59241e-06 | gnorm 5.137 | loss_scale 1 | train_wall 24 | wall 2026
2021-01-19 06:17:43 | INFO | fairseq_cli.train | begin training epoch 32
2021-01-19 06:17:53 | INFO | train_inner | epoch 033:     59 / 139 loss=3.035, nll_loss=1.208, ppl=2.31, wps=4389.8, ups=1.79, wpb=2449.4, bsz=75.7, num_updates=4500, lr=7.54247e-06, gnorm=4.674, loss_scale=1, train_wall=17, wall=2036
2021-01-19 06:18:07 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:18:07 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:18:07 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:18:08 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:18:08 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:18:09 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:18:09 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:18:11 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients) comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:18:11 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:18:11 | INFO | valid | epoch 033 | valid on 'valid' subset | loss 3.104 | nll_loss 1.104 | ppl 2.15 | bleu 52.83 | wps 1055.6 | wpb 1083 | bsz 37.8 | num_updates 4580 | best_loss 3.104
2021-01-19 06:18:11 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:18:45 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 33 @ 4580 updates, score 3.104) (writing took 34.15321912243962 seconds)
2021-01-19 06:18:45 | INFO | fairseq_cli.train | end of epoch 33 (average epoch stats below)
2021-01-19 06:18:45 | INFO | train | epoch 033 | loss 3.032 | nll_loss 1.204 | ppl 2.3 | wps 5493.6 | ups 2.23 | wpb 2458.3 | bsz 71.9 | num_updates 4580 | lr 7.47631e-06 | gnorm 4.789 | loss_scale 1 | train_wall 24 | wall 2088
2021-01-19 06:18:45 | INFO | fairseq_cli.train | begin training epoch 33
2021-01-19 06:18:49 | INFO | train_inner | epoch 034:     20 / 139 loss=3.028, nll_loss=1.199, ppl=2.3, wps=4406.3, ups=1.8, wpb=2451.2, bsz=69.2, num_updates=4600, lr=7.46004e-06, gnorm=4.804, loss_scale=1, train_wall=17, wall=2092
2021-01-19 06:19:06 | INFO | train_inner | epoch 034:    120 / 139 loss=3.022, nll_loss=1.193, ppl=2.29, wps=14130.9, ups=5.85, wpb=2417.4, bsz=69.5, num_updates=4700, lr=7.38025e-06, gnorm=4.929, loss_scale=1, train_wall=17, wall=2109
2021-01-19 06:19:09 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:19:10 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:19:10 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:19:10 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:19:10 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:19:11 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:19:11 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:19:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes in which the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes in which the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:19:13 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:19:13 | INFO | valid | epoch 034 | valid on 'valid' subset | loss 3.087 | nll_loss 1.081 | ppl 2.12 | bleu 53.49 | wps 1055.1 | wpb 1083 | bsz 37.8 | num_updates 4719 | best_loss 3.087
2021-01-19 06:19:13 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:19:48 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 34 @ 4719 updates, score 3.087) (writing took 34.8824851103127 seconds)
2021-01-19 06:19:48 | INFO | fairseq_cli.train | end of epoch 34 (average epoch stats below)
2021-01-19 06:19:48 | INFO | train | epoch 034 | loss 3.004 | nll_loss 1.173 | ppl 2.26 | wps 5427.6 | ups 2.21 | wpb 2458.3 | bsz 71.9 | num_updates 4719 | lr 7.36538e-06 | gnorm 4.761 | loss_scale 1 | train_wall 24 | wall 2151
2021-01-19 06:19:48 | INFO | fairseq_cli.train | begin training epoch 34
2021-01-19 06:20:02 | INFO | train_inner | epoch 035:     81 / 139 loss=2.992, nll_loss=1.16, ppl=2.23, wps=4395.2, ups=1.78, wpb=2472.4, bsz=73.2, num_updates=4800, lr=7.30297e-06, gnorm=5.15, loss_scale=1, train_wall=17, wall=2165
2021-01-19 06:20:12 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:20:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:20:13 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:20:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:20:13 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:20:14 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:20:14 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:20:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes in which the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes in which the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:20:16 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:20:16 | INFO | valid | epoch 035 | valid on 'valid' subset | loss 3.076 | nll_loss 1.067 | ppl 2.1 | bleu 54.82 | wps 1055 | wpb 1083 | bsz 37.8 | num_updates 4858 | best_loss 3.076
2021-01-19 06:20:16 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:20:51 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 35 @ 4858 updates, score 3.076) (writing took 34.56847411673516 seconds)
2021-01-19 06:20:51 | INFO | fairseq_cli.train | end of epoch 35 (average epoch stats below)
2021-01-19 06:20:51 | INFO | train | epoch 035 | loss 2.983 | nll_loss 1.149 | ppl 2.22 | wps 5462 | ups 2.22 | wpb 2458.3 | bsz 71.9 | num_updates 4858 | lr 7.25924e-06 | gnorm 5.571 | loss_scale 1 | train_wall 24 | wall 2214
2021-01-19 06:20:51 | INFO | fairseq_cli.train | begin training epoch 35
2021-01-19 06:20:58 | INFO | train_inner | epoch 036:     42 / 139 loss=2.934, nll_loss=1.093, ppl=2.13, wps=4430.6, ups=1.79, wpb=2478, bsz=72.3, num_updates=4900, lr=7.22806e-06, gnorm=5.581, loss_scale=1, train_wall=17, wall=2221
2021-01-19 06:21:15 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:21:15 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:21:15 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:21:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:21:16 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:21:17 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:21:17 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:21:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:21:19 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:21:19 | INFO | valid | epoch 036 | valid on 'valid' subset | loss 3.055 | nll_loss 1.045 | ppl 2.06 | bleu 55.23 | wps 1051.6 | wpb 1083 | bsz 37.8 | num_updates 4997 | best_loss 3.055
2021-01-19 06:21:19 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:21:54 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 36 @ 4997 updates, score 3.055) (writing took 35.31784580554813 seconds)
2021-01-19 06:21:54 | INFO | fairseq_cli.train | end of epoch 36 (average epoch stats below)
2021-01-19 06:21:54 | INFO | train | epoch 036 | loss 2.953 | nll_loss 1.115 | ppl 2.17 | wps 5396.5 | ups 2.2 | wpb 2458.3 | bsz 71.9 | num_updates 4997 | lr 7.15757e-06 | gnorm 4.721 | loss_scale 1 | train_wall 24 | wall 2277
2021-01-19 06:21:54 | INFO | fairseq_cli.train | begin training epoch 36
2021-01-19 06:21:55 | INFO | train_inner | epoch 037:      3 / 139 loss=2.96, nll_loss=1.123, ppl=2.18, wps=4374, ups=1.77, wpb=2475.8, bsz=73.2, num_updates=5000, lr=7.15542e-06, gnorm=4.5, loss_scale=1, train_wall=17, wall=2278
2021-01-19 06:22:12 | INFO | train_inner | epoch 037:    103 / 139 loss=2.931, nll_loss=1.09, ppl=2.13, wps=14200, ups=5.81, wpb=2444.9, bsz=70.9, num_updates=5100, lr=7.08492e-06, gnorm=5.072, loss_scale=1, train_wall=17, wall=2295
2021-01-19 06:22:18 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:22:18 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:22:18 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:22:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:22:19 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:22:20 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:22:20 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:22:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:22:22 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:22:22 | INFO | valid | epoch 037 | valid on 'valid' subset | loss 3.046 | nll_loss 1.033 | ppl 2.05 | bleu 55.71 | wps 1062.2 | wpb 1083 | bsz 37.8 | num_updates 5136 | best_loss 3.046
2021-01-19 06:22:22 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:22:58 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 37 @ 5136 updates, score 3.046) (writing took 35.90300048608333 seconds)
2021-01-19 06:22:58 | INFO | fairseq_cli.train | end of epoch 37 (average epoch stats below)
2021-01-19 06:22:58 | INFO | train | epoch 037 | loss 2.929 | nll_loss 1.089 | ppl 2.13 | wps 5351.3 | ups 2.18 | wpb 2458.3 | bsz 71.9 | num_updates 5136 | lr 7.06005e-06 | gnorm 4.858 | loss_scale 1 | train_wall 24 | wall 2341
2021-01-19 06:22:58 | INFO | fairseq_cli.train | begin training epoch 37
2021-01-19 06:23:09 | INFO | train_inner | epoch 038:     64 / 139 loss=2.883, nll_loss=1.037, ppl=2.05, wps=4238, ups=1.76, wpb=2413.3, bsz=72.2, num_updates=5200, lr=7.01646e-06, gnorm=4.327, loss_scale=1, train_wall=17, wall=2352
2021-01-19 06:23:22 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:23:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:23:22 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:23:23 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:23:23 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:23:24 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:23:24 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:23:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:23:26 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:23:26 | INFO | valid | epoch 038 | valid on 'valid' subset | loss 3.03 | nll_loss 1.015 | ppl 2.02 | bleu 56.17 | wps 998.1 | wpb 1083 | bsz 37.8 | num_updates 5275 | best_loss 3.03
2021-01-19 06:23:26 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:24:01 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 38 @ 5275 updates, score 3.03) (writing took 34.820467522367835 seconds)
2021-01-19 06:24:01 | INFO | fairseq_cli.train | end of epoch 38 (average epoch stats below)
2021-01-19 06:24:01 | INFO | train | epoch 038 | loss 2.91 | nll_loss 1.066 | ppl 2.09 | wps 5416.8 | ups 2.2 | wpb 2458.3 | bsz 71.9 | num_updates 5275 | lr 6.96641e-06 | gnorm 4.667 | loss_scale 1 | train_wall 24 | wall 2404
2021-01-19 06:24:01 | INFO | fairseq_cli.train | begin training epoch 38
2021-01-19 06:24:05 | INFO | train_inner | epoch 039:     25 / 139 loss=2.922, nll_loss=1.082, ppl=2.12, wps=4537.6, ups=1.77, wpb=2570.6, bsz=74.5, num_updates=5300, lr=6.94996e-06, gnorm=4.736, loss_scale=1, train_wall=17, wall=2408
2021-01-19 06:24:23 | INFO | train_inner | epoch 039:    125 / 139 loss=2.912, nll_loss=1.069, ppl=2.1, wps=14023.3, ups=5.82, wpb=2409, bsz=70.6, num_updates=5400, lr=6.8853e-06, gnorm=4.856, loss_scale=1, train_wall=17, wall=2426
2021-01-19 06:24:25 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:24:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:24:25 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:24:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin preparations.
2021-01-19 06:24:26 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:24:27 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:24:27 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:24:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:24:29 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:24:29 | INFO | valid | epoch 039 | valid on 'valid' subset | loss 3.026 | nll_loss 1.009 | ppl 2.01 | bleu 57.15 | wps 1019.5 | wpb 1083 | bsz 37.8 | num_updates 5414 | best_loss 3.026
2021-01-19 06:24:29 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:25:05 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 39 @ 5414 updates, score 3.026) (writing took 35.536035316996276 seconds)
2021-01-19 06:25:05 | INFO | fairseq_cli.train | end of epoch 39 (average epoch stats below)
2021-01-19 06:25:05 | INFO | train | epoch 039 | loss 2.891 | nll_loss 1.045 | ppl 2.06 | wps 5364.3 | ups 2.18 | wpb 2458.3 | bsz 71.9 | num_updates 5414 | lr 6.8764e-06 | gnorm 4.732 | loss_scale 1 | train_wall 24 | wall 2468
2021-01-19 06:25:05 | INFO | fairseq_cli.train | begin training epoch 39
2021-01-19 06:25:19 | INFO | train_inner | epoch 040:     86 / 139 loss=2.883, nll_loss=1.037, ppl=2.05, wps=4278.5, ups=1.76, wpb=2436.8, bsz=71.5, num_updates=5500, lr=6.82242e-06, gnorm=4.737, loss_scale=1, train_wall=17, wall=2483
2021-01-19 06:25:29 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:25:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:25:29 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:25:30 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:25:30 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:25:31 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:25:31 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:25:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:25:33 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:25:33 | INFO | valid | epoch 040 | valid on 'valid' subset | loss 3.016 | nll_loss 0.996 | ppl 2 | bleu 58.28 | wps 968.6 | wpb 1083 | bsz 37.8 | num_updates 5553 | best_loss 3.016
2021-01-19 06:25:33 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:26:09 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 40 @ 5553 updates, score 3.016) (writing took 35.87985804025084 seconds)
2021-01-19 06:26:09 | INFO | fairseq_cli.train | end of epoch 40 (average epoch stats below)
2021-01-19 06:26:09 | INFO | train | epoch 040 | loss 2.87 | nll_loss 1.022 | ppl 2.03 | wps 5315.2 | ups 2.16 | wpb 2458.3 | bsz 71.9 | num_updates 5553 | lr 6.78979e-06 | gnorm 4.546 | loss_scale 1 | train_wall 24 | wall 2532
2021-01-19 06:26:09 | INFO | fairseq_cli.train | begin training epoch 40
2021-01-19 06:26:17 | INFO | train_inner | epoch 041:     47 / 139 loss=2.864, nll_loss=1.015, ppl=2.02, wps=4333, ups=1.74, wpb=2493.8, bsz=70.6, num_updates=5600, lr=6.76123e-06, gnorm=4.189, loss_scale=1, train_wall=17, wall=2540
2021-01-19 06:26:33 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:26:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:26:33 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:26:34 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:26:34 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:26:35 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:26:35 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:26:37 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:26:37 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:26:37 | INFO | valid | epoch 041 | valid on 'valid' subset | loss 3.009 | nll_loss 0.988 | ppl 1.98 | bleu 58.52 | wps 979.3 | wpb 1083 | bsz 37.8 | num_updates 5692 | best_loss 3.009
2021-01-19 06:26:37 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:27:14 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 41 @ 5692 updates, score 3.009) (writing took 36.79756445251405 seconds)
2021-01-19 06:27:14 | INFO | fairseq_cli.train | end of epoch 41 (average epoch stats below)
2021-01-19 06:27:14 | INFO | train | epoch 041 | loss 2.849 | nll_loss 0.998 | ppl 2 | wps 5243.7 | ups 2.13 | wpb 2458.3 | bsz 71.9 | num_updates 5692 | lr 6.70637e-06 | gnorm 4.018 | loss_scale 1 | train_wall 24 | wall 2597
2021-01-19 06:27:14 | INFO | fairseq_cli.train | begin training epoch 41
2021-01-19 06:27:16 | INFO | train_inner | epoch 042:      8 / 139 loss=2.815, nll_loss=0.961, ppl=1.95, wps=4223.5, ups=1.71, wpb=2471, bsz=74.5, num_updates=5700, lr=6.70166e-06, gnorm=3.992, loss_scale=1, train_wall=17, wall=2599
2021-01-19 06:27:33 | INFO | train_inner | epoch 042:    108 / 139 loss=2.844, nll_loss=0.993, ppl=1.99, wps=14095.7, ups=5.79, wpb=2435.8, bsz=72.7, num_updates=5800, lr=6.64364e-06, gnorm=5.632, loss_scale=1, train_wall=17, wall=2616
2021-01-19 06:27:38 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:27:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:27:39 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:27:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:27:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:27:40 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:27:40 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:27:42 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring a substance in the blood called glycosylated haemoglobin (HbA1c) that indicates how well the blood glucose is controlled for six months.
2021-01-19 06:27:42 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:27:42 | INFO | valid | epoch 042 | valid on 'valid' subset | loss 3.002 | nll_loss 0.98 | ppl 1.97 | bleu 59.92 | wps 1000.9 | wpb 1083 | bsz 37.8 | num_updates 5831 | best_loss 3.002
2021-01-19 06:27:42 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:28:18 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 42 @ 5831 updates, score 3.002) (writing took 35.39976074639708 seconds)
2021-01-19 06:28:18 | INFO | fairseq_cli.train | end of epoch 42 (average epoch stats below)
2021-01-19 06:28:18 | INFO | train | epoch 042 | loss 2.832 | nll_loss 0.98 | ppl 1.97 | wps 5371.2 | ups 2.18 | wpb 2458.3 | bsz 71.9 | num_updates 5831 | lr 6.62595e-06 | gnorm 5.447 | loss_scale 1 | train_wall 24 | wall 2661
2021-01-19 06:28:18 | INFO | fairseq_cli.train | begin training epoch 42
2021-01-19 06:28:30 | INFO | train_inner | epoch 043:     69 / 139 loss=2.784, nll_loss=0.927, ppl=1.9, wps=4406.8, ups=1.76, wpb=2505.6, bsz=74.5, num_updates=5900, lr=6.5871e-06, gnorm=4.286, loss_scale=1, train_wall=17, wall=2673
2021-01-19 06:28:42 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:28:42 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:28:42 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:28:43 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:28:43 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:28:44 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:28:44 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:28:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:28:46 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:28:46 | INFO | valid | epoch 043 | valid on 'valid' subset | loss 2.988 | nll_loss 0.965 | ppl 1.95 | bleu 60.22 | wps 987.4 | wpb 1083 | bsz 37.8 | num_updates 5970 | best_loss 2.988
2021-01-19 06:28:46 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:29:22 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 43 @ 5970 updates, score 2.988) (writing took 35.732057712972164 seconds)
2021-01-19 06:29:22 | INFO | fairseq_cli.train | end of epoch 43 (average epoch stats below)
2021-01-19 06:29:22 | INFO | train | epoch 043 | loss 2.812 | nll_loss 0.957 | ppl 1.94 | wps 5331.1 | ups 2.17 | wpb 2458.3 | bsz 71.9 | num_updates 5970 | lr 6.54836e-06 | gnorm 4.021 | loss_scale 1 | train_wall 24 | wall 2725
2021-01-19 06:29:22 | INFO | fairseq_cli.train | begin training epoch 43
2021-01-19 06:29:27 | INFO | train_inner | epoch 044:     30 / 139 loss=2.86, nll_loss=1.009, ppl=2.01, wps=4239.9, ups=1.74, wpb=2430.4, bsz=67.3, num_updates=6000, lr=6.53197e-06, gnorm=4.713, loss_scale=1, train_wall=17, wall=2730
2021-01-19 06:29:44 | INFO | train_inner | epoch 044:    130 / 139 loss=2.795, nll_loss=0.938, ppl=1.92, wps=14010.1, ups=5.81, wpb=2411.2, bsz=72.2, num_updates=6100, lr=6.47821e-06, gnorm=4.592, loss_scale=1, train_wall=17, wall=2747
2021-01-19 06:29:46 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:29:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:29:46 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:29:47 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:29:47 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:29:48 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:29:48 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:29:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:29:50 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:29:50 | INFO | valid | epoch 044 | valid on 'valid' subset | loss 2.982 | nll_loss 0.957 | ppl 1.94 | bleu 60.45 | wps 1008 | wpb 1083 | bsz 37.8 | num_updates 6109 | best_loss 2.982
2021-01-19 06:29:50 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:30:28 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 44 @ 6109 updates, score 2.982) (writing took 37.96342861652374 seconds)
2021-01-19 06:30:28 | INFO | fairseq_cli.train | end of epoch 44 (average epoch stats below)
2021-01-19 06:30:28 | INFO | train | epoch 044 | loss 2.803 | nll_loss 0.947 | ppl 1.93 | wps 5162.3 | ups 2.1 | wpb 2458.3 | bsz 71.9 | num_updates 6109 | lr 6.47344e-06 | gnorm 4.959 | loss_scale 1 | train_wall 24 | wall 2791
2021-01-19 06:30:28 | INFO | fairseq_cli.train | begin training epoch 44
2021-01-19 06:30:44 | INFO | train_inner | epoch 045:     91 / 139 loss=2.764, nll_loss=0.904, ppl=1.87, wps=4212.9, ups=1.68, wpb=2503.2, bsz=77.2, num_updates=6200, lr=6.42575e-06, gnorm=4.164, loss_scale=1, train_wall=17, wall=2807
2021-01-19 06:30:52 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:30:52 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:30:52 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:30:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:30:53 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:30:54 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:30:54 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:30:56 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:30:56 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:30:56 | INFO | valid | epoch 045 | valid on 'valid' subset | loss 2.977 | nll_loss 0.949 | ppl 1.93 | bleu 60.66 | wps 962.7 | wpb 1083 | bsz 37.8 | num_updates 6248 | best_loss 2.977
2021-01-19 06:30:56 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:31:32 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 45 @ 6248 updates, score 2.977) (writing took 35.9741479549557 seconds)
2021-01-19 06:31:32 | INFO | fairseq_cli.train | end of epoch 45 (average epoch stats below)
2021-01-19 06:31:32 | INFO | train | epoch 045 | loss 2.785 | nll_loss 0.927 | ppl 1.9 | wps 5309.8 | ups 2.16 | wpb 2458.3 | bsz 71.9 | num_updates 6248 | lr 6.40102e-06 | gnorm 4.054 | loss_scale 1 | train_wall 24 | wall 2855
2021-01-19 06:31:32 | INFO | fairseq_cli.train | begin training epoch 45
2021-01-19 06:31:42 | INFO | train_inner | epoch 046:     52 / 139 loss=2.801, nll_loss=0.945, ppl=1.92, wps=4241.3, ups=1.73, wpb=2456.1, bsz=69.8, num_updates=6300, lr=6.37455e-06, gnorm=4.125, loss_scale=1, train_wall=17, wall=2865
2021-01-19 06:31:56 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:31:57 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:31:57 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:31:58 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:31:58 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:31:59 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:31:59 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:32:01 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin aspart) by measuring a substance in the blood called glycosylated haemoglobin (HbA1c) for six months, which indicates how well the blood glucose is controlled.
2021-01-19 06:32:01 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:32:01 | INFO | valid | epoch 046 | valid on 'valid' subset | loss 2.976 | nll_loss 0.947 | ppl 1.93 | bleu 61.29 | wps 1003.6 | wpb 1083 | bsz 37.8 | num_updates 6387 | best_loss 2.976
2021-01-19 06:32:01 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:32:41 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 46 @ 6387 updates, score 2.976) (writing took 40.06912340596318 seconds)
2021-01-19 06:32:41 | INFO | fairseq_cli.train | end of epoch 46 (average epoch stats below)
2021-01-19 06:32:41 | INFO | train | epoch 046 | loss 2.77 | nll_loss 0.91 | ppl 1.88 | wps 5000.4 | ups 2.03 | wpb 2458.3 | bsz 71.9 | num_updates 6387 | lr 6.33099e-06 | gnorm 4.372 | loss_scale 1 | train_wall 24 | wall 2924
2021-01-19 06:32:41 | INFO | fairseq_cli.train | begin training epoch 46
2021-01-19 06:32:43 | INFO | train_inner | epoch 047:     13 / 139 loss=2.76, nll_loss=0.897, ppl=1.86, wps=3935.8, ups=1.63, wpb=2417.1, bsz=68.9, num_updates=6400, lr=6.32456e-06, gnorm=4.409, loss_scale=1, train_wall=17, wall=2926
2021-01-19 06:33:00 | INFO | train_inner | epoch 047:    113 / 139 loss=2.749, nll_loss=0.887, ppl=1.85, wps=14053.9, ups=5.81, wpb=2418.9, bsz=69, num_updates=6500, lr=6.27572e-06, gnorm=4.172, loss_scale=1, train_wall=17, wall=2943
2021-01-19 06:33:05 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:33:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:33:05 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:33:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:33:06 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:33:07 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:33:07 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:33:09 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:33:09 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:33:09 | INFO | valid | epoch 047 | valid on 'valid' subset | loss 2.97 | nll_loss 0.942 | ppl 1.92 | bleu 62.19 | wps 988.2 | wpb 1083 | bsz 37.8 | num_updates 6526 | best_loss 2.97
2021-01-19 06:33:09 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:33:44 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 47 @ 6526 updates, score 2.97) (writing took 35.33427134901285 seconds)
2021-01-19 06:33:44 | INFO | fairseq_cli.train | end of epoch 47 (average epoch stats below)
2021-01-19 06:33:44 | INFO | train | epoch 047 | loss 2.753 | nll_loss 0.891 | ppl 1.85 | wps 5372.7 | ups 2.19 | wpb 2458.3 | bsz 71.9 | num_updates 6526 | lr 6.2632e-06 | gnorm 4.053 | loss_scale 1 | train_wall 24 | wall 2987
2021-01-19 06:33:44 | INFO | fairseq_cli.train | begin training epoch 47
2021-01-19 06:33:57 | INFO | train_inner | epoch 048:     74 / 139 loss=2.759, nll_loss=0.897, ppl=1.86, wps=4414.8, ups=1.75, wpb=2516.3, bsz=75.4, num_updates=6600, lr=6.22799e-06, gnorm=3.907, loss_scale=1, train_wall=17, wall=3000
2021-01-19 06:34:08 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:34:09 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:34:09 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:34:10 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:34:10 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:34:11 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:34:11 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:34:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:34:13 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:34:13 | INFO | valid | epoch 048 | valid on 'valid' subset | loss 2.957 | nll_loss 0.925 | ppl 1.9 | bleu 62.65 | wps 985.5 | wpb 1083 | bsz 37.8 | num_updates 6665 | best_loss 2.957
2021-01-19 06:34:13 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:34:48 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 48 @ 6665 updates, score 2.957) (writing took 35.60119904670864 seconds)
2021-01-19 06:34:48 | INFO | fairseq_cli.train | end of epoch 48 (average epoch stats below)
2021-01-19 06:34:48 | INFO | train | epoch 048 | loss 2.749 | nll_loss 0.888 | ppl 1.85 | wps 5343.9 | ups 2.17 | wpb 2458.3 | bsz 71.9 | num_updates 6665 | lr 6.19755e-06 | gnorm 4.413 | loss_scale 1 | train_wall 24 | wall 3051
2021-01-19 06:34:48 | INFO | fairseq_cli.train | begin training epoch 48
2021-01-19 06:34:54 | INFO | train_inner | epoch 049:     35 / 139 loss=2.739, nll_loss=0.877, ppl=1.84, wps=4236.4, ups=1.75, wpb=2420.1, bsz=69.8, num_updates=6700, lr=6.18134e-06, gnorm=4.447, loss_scale=1, train_wall=17, wall=3057
2021-01-19 06:35:11 | INFO | train_inner | epoch 049:    135 / 139 loss=2.725, nll_loss=0.858, ppl=1.81, wps=14440, ups=5.82, wpb=2480.2, bsz=73.5, num_updates=6800, lr=6.13572e-06, gnorm=3.794, loss_scale=1, train_wall=17, wall=3075
2021-01-19 06:35:12 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:35:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:35:13 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:35:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-01-19 06:35:13 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:35:15 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:35:15 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:35:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin aspart) by measuring a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:35:16 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:35:17 | INFO | valid | epoch 049 | valid on 'valid' subset | loss 2.952 | nll_loss 0.922 | ppl 1.89 | bleu 63.42 | wps 969 | wpb 1083 | bsz 37.8 | num_updates 6804 | best_loss 2.952
2021-01-19 06:35:17 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:35:51 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 49 @ 6804 updates, score 2.952) (writing took 34.93952852208167 seconds)
2021-01-19 06:35:51 | INFO | fairseq_cli.train | end of epoch 49 (average epoch stats below)
2021-01-19 06:35:51 | INFO | train | epoch 049 | loss 2.732 | nll_loss 0.867 | ppl 1.82 | wps 5396.5 | ups 2.2 | wpb 2458.3 | bsz 71.9 | num_updates 6804 | lr 6.13392e-06 | gnorm 3.73 | loss_scale 1 | train_wall 24 | wall 3115
2021-01-19 06:35:51 | INFO | fairseq_cli.train | begin training epoch 49
2021-01-19 06:36:08 | INFO | train_inner | epoch 050:     96 / 139 loss=2.75, nll_loss=0.889, ppl=1.85, wps=4372.4, ups=1.76, wpb=2478.7, bsz=70.6, num_updates=6900, lr=6.0911e-06, gnorm=3.928, loss_scale=1, train_wall=17, wall=3131
2021-01-19 06:36:15 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:36:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:36:16 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:36:17 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be used in combination with long-acting insulin preparations.
2021-01-19 06:36:17 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:36:18 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions termed acute painful neuropathy, which are usually reversible.
2021-01-19 06:36:18 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:36:20 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients in whom the pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetes in whom the body cannot process insulin effectively (one study involving 182 patients), comparing Actrapide to a human insulin analogue (insulin Aspart) by measuring a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-01-19 06:36:20 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:36:20 | INFO | valid | epoch 050 | valid on 'valid' subset | loss 2.95 | nll_loss 0.915 | ppl 1.89 | bleu 64.98 | wps 977.3 | wpb 1083 | bsz 37.8 | num_updates 6943 | best_loss 2.95
2021-01-19 06:36:20 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:36:55 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_17/checkpoint_best.pt (epoch 50 @ 6943 updates, score 2.95) (writing took 35.33051024843007 seconds)
2021-01-19 06:36:55 | INFO | fairseq_cli.train | end of epoch 50 (average epoch stats below)
2021-01-19 06:36:55 | INFO | train | epoch 050 | loss 2.721 | nll_loss 0.857 | ppl 1.81 | wps 5372.1 | ups 2.19 | wpb 2458.3 | bsz 71.9 | num_updates 6943 | lr 6.0722e-06 | gnorm 3.968 | loss_scale 1 | train_wall 24 | wall 3178
2021-01-19 06:36:55 | INFO | fairseq_cli.train | done training in 3175.5 seconds


###############################################################################
Peregrine Cluster
Job 17437475 for user 's3475743'
Finished at: Tue Jan 19 06:36:57 CET 2021

Job details:
============

Job ID              : 17437475
Name                : EMEA_17
User                : s3475743
Partition           : gpu
Nodes               : pg-gpu28
Number of Nodes     : 1
Cores               : 12
State               : COMPLETED
Submit              : 2021-01-19T04:45:28
Start               : 2021-01-19T05:43:45
End                 : 2021-01-19T06:36:57
Reserved walltime   : 23:55:00
Used walltime       : 00:53:12
Used CPU time       : 00:38:01 (efficiency:  5.96%)
% User (Computation): 51.72%
% System (I/O)      : 48.28%
Mem reserved        : 32G/node
Max Mem used        : 5.63G (pg-gpu28)
Max Disk Write      : 40.96K (pg-gpu28)
Max Disk Read       : 2.30M (pg-gpu28)
Average GPU usage   : 42.6% (pg-gpu28)


Acknowledgements:
=================

Please see this page for information about acknowledging Peregrine in your publications:

https://wiki.hpc.rug.nl/peregrine/introduction/scientific_output

################################################################################
